Abstract
Background
KAR™ prosthesis was introduced following the success of Corail® femoral stem to tackle difficult revision cases (Paprosky type1, 2a, 2b and 3a). The ARTO group reported a success rate of 94% at 17 years follow-up. Only two independent studies reported similar success rate to date.
Purpose
To analyse the short-term performance of the KAR™ prosthesis used in our unit.
Methods
This was a retrospective study of all KAR™ prosthesis between 2005 and 2013. Basic demographic, stem size, indications, failures and complications were recorded. X-rays were analysed for evidence of implant failure and distal cortical hypertrophy.
Results
A total of 83 cases were analysed. The mean age was 68 (range 38–88 years) with an average follow-up was 3 years (range 1–8 years). The main indications for revision were aseptic loosening (83.7%), and periprosthetic fractures (7%). Kaplan-Meier Survival Rate for ‘all reasons of failure’ and ‘stem loosening’ was 93.83% and 100% respectively at 3 years follow-up. The most common reason for failure following KAR™ revision was periprosthetic fracture (3 cases). All three cases had radiographic evidence of proximal bone loss prior to index revision. Two patients developed deep infection and one patient had stem subsidence requiring revision. One patient sustained dislocation but revision surgery was not required. When comparing the effect of cortical hypertrophy, there were no significant differences in the measured distal canal/cortical diameter over the entire period of follow-up.
Discussion
KAR™ prosthesis offers respectable clinical performance over a short-term period. Revision rate for this system was comparable to other ‘independent non-designer’ study. The three patients that sustained periprosthetic fracture may have been better served with a distally locked stem revision system. We believe that this HA coated implant encourages consistent osseointegration around the metaphysis region when there is evidence of a sound distal fixation.
Conclusion
This study confirms that this fully coated hydroxyapatite titanium stem offers reliable clinical performance in revision arthroplasty.
